title: alpha 2-Adrenoceptors in the HT 29 human colon adenocarcinoma cell line: characterization with [3H]clonidine; effects on cyclic AMP accumulation.
abstract: In the present work, [3H]clonidine was used to characterize alpha 2-adrenoceptors on the human adenocarcinoma cell line HT 29. The effects of alpha 2-adrenergic stimulation on cellular cyclic AMP levels were also investigated. The binding of [3H]clonidine on HT 29 cell membrane preparations was rapid and reversible. Scatchard analysis of the saturation curves indicated the existence of a single class of non-interacting sites with a KD of 1.29 +/- 0.07 nM and a Bmax of 114 +/- 7 fmol/mg of cell membrane protein. The binding sites for [3H]clonidine showed the required specificity for alpha 2-adrenoceptors. The potencies of alpha-adrenergic compounds to displace [3H]clonidine binding ranked as follows: yohimbine greater than phentolamine much greater than prazosin for antagonists and clonidine greater than epinephrine greater than norepinephrine greater than phenylephrine much greater than amidephrine for agonists. When tested on intact cells, epinephrine, norepinephrine and clonidine were found to counteract, in a dose-dependent manner, the increase of cyclic AMP triggered by vasoactive intestinal peptide (VIP). Such inhibitory effects were abolished by the addition of yohimbine but not of prazosin. The physiological amines were the most efficient agonists: both epinephrine and norepinephrine inhibited VIP-induced cyclic AMP accumulation by 50-55% with KD values of 50 nM and 300 nM respectively. Clonidine was a partial agonist only, provoking a weak (25-30%) inhibition of VIP-induced cyclic AMP accumulation even at high concentrations. These results indicate that, like normal colocytes, human colon adenocarcinoma cells HT 29 possess alpha 2-adrenoceptors, the stimulation of which is associated with an inhibition of cyclic AMP production.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.forename: B
authors.initials: B
authors.lastname: Bouscarel
authors.forename: C
authors.initials: C
authors.lastname: Cortinovis
authors.forename: C
authors.initials: C
authors.lastname: Carpene
authors.forename: J C
authors.initials: JC
authors.lastname: Murat
authors.forename: H
authors.initials: H
authors.lastname: Paris
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism*; D002460:Cell Line; D003000:Clonidine / Q000378:metabolism*; D003110:Colonic Neoplasms / Q000378:metabolism*; D000242:Cyclic AMP / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism* / Q000502:physiology; D014316:Tritium; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology
chemical_list: D011942:Receptors, Adrenergic, alpha; D014316:Tritium; D014660:Vasoactive Intestinal Peptide; D000242:Cyclic AMP; D003000:Clonidine